BillionToOne Inc. Class A Common Stock
BLLNUnited States
6 filed reports · 281 financial concepts · 1 earnings calls · 3 media appearances
Filed reports
6 reports · Sep 2025 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 2 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 3 | 714 | Sep 2025 to Jun 2026 |
| Current · 8-KSEC EDGAR | 2 | 4 | Mar 2026 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 812 | Dec 2025 |
Documents
Financial data
281 concepts · 1,530 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial277 concepts · 1,489 facts · Jul 2022 to Jun 2026
- Stockholders equity (US GAAP)13 · Dec 2023 to Jun 2026
- Temporary equity carrying amount attributable to parent13 · Dec 2023 to Jun 2026
- Temporary equity shares outstanding13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents12 · Dec 2023 to Jun 2026
- Change in fair value of term loan12 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value11 · Dec 2023 to Jun 2026
- Allocated share based compensation expense11 · Dec 2023 to Jun 2026
- Comprehensive income net of tax11 · Dec 2023 to Jun 2026
- Contract with customer liability revenue recognized11 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)11 · Dec 2023 to Jun 2026
- Defined contribution plan cost recognized11 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)11 · Dec 2023 to Jun 2026
- Income tax expense benefit11 · Dec 2023 to Jun 2026
- Incremental common shares attributable to share based payment arrangements11 · Dec 2023 to Jun 2026
- Interest expense nonoperating11 · Dec 2023 to Jun 2026
- Investment income interest11 · Dec 2023 to Jun 2026
- Net income loss11 · Dec 2023 to Jun 2026
- Net income loss available to common stockholders diluted11 · Dec 2023 to Jun 2026
- Nonoperating income expense11 · Dec 2023 to Jun 2026
- Operating expenses (US GAAP)11 · Dec 2023 to Jun 2026
- Operating income loss11 · Dec 2023 to Jun 2026
- Other nonoperating income expense11 · Dec 2023 to Jun 2026
- Research and development expense11 · Dec 2023 to Jun 2026
- Revenue11 · Dec 2023 to Jun 2026
Product1 concepts · 33 facts · Dec 2023 to Jun 2026
- Revenue33 · Dec 2023 to Jun 2026
KPI2 concepts · 6 facts · Sep 2025 to Jun 2026
- Diagnostic Test Volume4 · Sep 2025 to Jun 2026
- Diagnostic Test Volume YoY Change2 · Mar 2026 to Jun 2026
Guidance1 concepts · 2 facts · Aug 2026
- Revenue Guidance2 · Aug 2026
Segments
33 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service3 members · 33 facts
- Clinical Trial Support And Other Services11 · Dec 2023 to Jun 2026
- Oncology11 · Dec 2023 to Jun 2026
- Prenatal11 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary42 claims from 5 reports · Sep 2025 to Jun 2026
- Management discussion (MD&A) commentary119 claims from 4 reports · Sep 2025 to Jun 2026
- Risk factors61 risks from 1 annual reports · 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
Executive media
3 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances3 · Apr 2020 to Jun 2024
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.